Table 2.
Immobilized Protein | Analyte | Kd (μM)1 |
---|---|---|
| ||
GST-CBL47–435 | ||
WT | UbcH5B | 311 ± 25 |
M222F | UbcH5B | 320 ± 27 |
M222E | UbcH5B | 70 ± 8 |
Y371F | UbcH5B | 250 ± 6 |
Y368F | UbcH5B | 138 ± 4 |
Y368F pY371 | UbcH5B | 28 ± 1 |
Y368F pY371 K389A | UbcH5B | 81 ± 2 |
Y368F pY371 V431A | UbcH5B | 43 ± 2 |
WT | UbcH5B K4A | 619 ± 140 |
M222F | UbcH5B K4A | 595 ± 120 |
M222E | UbcH5B K4A | 225 ± 10 |
WT | UbcH5B + ZAP-70 peptide2 | 244 ± 7 |
WT | ZAP-70 peptide | 17 ± 0.4 |
Y368F pY371 | ZAP-70 peptide | 11 ± 1 |
| ||
GST-CBL354–435 | ||
WT | UbcH5B | 42 ± 2 |
pY3713 | UbcH5B | 20 ± 1 |
Y368F | UbcH5B | 38 ± 2 |
Y368F pY371 | UbcH5B | 18 ± 1 |
Y371F | UbcH5B | 50 ± 3 |
s.e.m. are indicated. Number of replicates, representative sensorgrams and binding curves are shown in Supplementary Fig. 3.
Due to the weak E2 binding, we could not saturate E2 concentrations for some of these measurements. The Kd values were approximated by fitting data obtained from 0–90 μM E2 using steady state affinity analyses.
Saturated ZAP-70 peptide (100 μM) was included in the analyte.
This sample contained trace amounts of GST-CBL354–435 pY368.